Graphical abstract Liposomes have been extensively used in various clinical treatments, including anti-tumor, anti-fungal, anti-bacterial, and clinical analgesia. In particular, two liposomal vaccines were approved in 2021 to combat COVID-19. The challenges of developing liposomes and the cutting-edge liposome delivery for combination and RNA therapy will be discussed in this review. Image, graphical abstract
All Keywords
【저자키워드】 COVID-19 pandemic, liposomes, drug delivery, Clinical application,
【저자키워드】 COVID-19 pandemic, liposomes, drug delivery, Clinical application,